We have humanized PD-1 and CTLA4 molecules, which are the target molecules of cancer immunotherapy, and created mice expressing human PD-1 and human CTLA4 molecules. If you are interested, please let us know.
Professor Tsubata was appointed as an Editorial Board Member of PLoS Biology (Impact Factor 9.163, 2017).
Feng Yang-yang (D3) won the first place and best discussion award at the "Intractable Disease Research Institute Research Presentation" held at our university on March 14th.
Please see the album for details.
2018.12 Mr. Li Xuexin (D1) won the Best Presentation Award at the 47th Annual Meeting of the Japanese Society for Immunology held in Fukuoka on December 10-12.
The 13th International Conference on Protein Phosphatases, "Workshop on Frontiers in Phosphatase Research and Drug Discovery," held at our university on October 23-25, ended successfully. Thank you to everyone who participated. Please click here to see the event.
2018.8 We welcomed students for the internship of Immunology Summer School 2018. Please see the album for details .
"Success in developing an immunostimulant that does not cause inflammation - Hopes for application in safer vaccine development - [Professor Takeshi Tsubata]" This research result was published in the online version of the international scientific journal Frontiers in Immunology on April 19, 2018.
For details, please see the press release (Tokyo Medical and Dental University).
We held a farewell party for three graduating students. Please see the album for details .
Two graduate students from our laboratory won the Excellence Award at the "Intractable Disease Research Institute Research Presentation" held on March 1, 2018. Please see the album for details .
